Generic Sustiva Will Launch In Thailand
This article was originally published in PharmAsia News
Executive Summary
Merck subsidiary Merck, Sharp & Dohme is requesting a meeting with the Thai Ministry of Health to discuss the government's decision to allow generic versions of the HIV/AIDS treatment efavirenz to launch in that country